Patient | Sex | Age at diagnosis | Age at start of treatment | New symptoms under therapy | Age at last visit | Subtype | Chitotriosidase | Filipin staining | Cholesterol esterification | Bone marrow | Genetics ( NPC1 ) |
---|---|---|---|---|---|---|---|---|---|---|---|
1a* | m | 30 | 31 | - | 33 | Juvenile | Normal | Clearly abnormal | na | Sea blue histiocytes, foam cells | p.Arg978Cys/delX1-X6 |
1b* | f | 27 | 28 | Mild Polyneuropathy | 30 | Adult | 9.9 mU/ml (0.0–4.6) | Clearly abnormal | na | na | p.Arg978Cys/delX1-X6 |
1c* | f | 22 | 22 | - | 24 | Adult | Normal | Clearly abnormal | na | na | p.Arg978Cys/delX1-X6 |
2a* | f | 15 | 30 (− 32) | - | †32 | Juvenile | 8.2 mU/ml (0.0–4.6) | Clearly abnormal | Abnormal | Sea blue histiocytes, foam cells | p.Pro474Leu/p.Ile1094Thr |
2b* | m | 19 | 29 | - | 35 | Juvenile | Normal | Clearly abnormal | na | Sea blue histiocytes, foam cells | p.Pro474Leu/p.Ile1094Thr |
3a | m | 15 | - | - | 15 | Juvenile | Normal | Variant | na | na | p.Ser940Leu/p.Pro1007Ala |
3b | f | 10 | - | - | 10 | Juvenile | Normal | na | na | na | p.Ser940Leu/p.Pro1007Ala |
4a* | m | 18 | 29 | Dysphagia | 29 | Juvenile | 11.3 mU/ml (0.3–3.7) | Clearly abnormal | na | Sea blue histiocytes, foam cells | p.Ile1061Thr/p.Ile1061Thr |
4b* | m | 16 | 27 | Dysphagia, dystonia, seizures | 27 | Juvenile | 4.4 mU/ml (0.3–3.7) | Clearly abnormal | na | Sea blue histiocytes, foam cells | p.Ile1061Thr/p.Ile1061Thr |
5 | m | 2 | 3 | VSGP | 5 | Late-infantile | 24.5 mU/ml (0.0–1.03) | Variant | na | Sea blue histiocytes, foam cells | p.Ile1067Thr/p.Asp948Asn |
6 | m | 7.5 | - | - | †7.5 | Late-infantile | na | Clearly abnormal | na | Foam cells | c.1554-1009G > A (intron 9)/p.Tyr1081* |
7 | f | 50 | 50 | Dysphagia | 51 | Adult | Normal | Clearly abnormal | na | Sea blue histiocytes, foam cells | p.Asp898Asn/ p.Pro1245Cysfs*12 |
8 | f | 23 | 24 | - | 25 | Adult | Normal | Clearly abnormal | na | na | na |
9 | f | 15 | - | - | †25 | Juvenile | na | Clearly abnormal | Abnormal | na | na |